Impact of renal function on argatroban therapy during percutaneous coronary intervention
Secondary prevention strategies for coronary heart disease
The actuarial survival analysis of the surgical and non-surgical therapy regimen for chronic thromboembolic pulmonary hypertension
Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease
Circulating p53 and cytochrome c levels in acute myocardial infarction patients
Soluble endothelial protein C receptor levels in healthy population
The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent
Metabolism, pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban in rabbits
Comparison of modes of prothrombin time reporting in patients with advanced liver disease associated with viral hepatitis
Thyroid-associated autoimmune coagulation disorders
Newer anticoagulants in 2009
Superior mesenteric artery thrombosis managed percutaneously by timely combining aspiration thrombectomy with angioplasty and stents
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease
Association of three polymorphisms selected from a genome-wide association study with coronary heart disease in the Tunisian population
Factor Xa-like and fibrin(ogen)olytic activities of a serine protease from Hippasa agelenoides spider venom gland extract
Interatrial thrombus-in-transit resulting in paradoxical thromboembolism
A necrotic skin lesion in a dialysis patient after the initiation of warfarin therapy
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention
Apixaban